"Multiprofile Hospital for Active Treatment - Uni Hospital" OOD Trials

"Multiprofile Hospital for Active Treatment - Uni Hospital" OOD	Welcome, Profile Billing Logout

"Multiprofile Hospital for Active Treatment - Uni Hospital" OOD

Welcome, Profile Billing Logout

0 Trials

2 Trials

Active Trials

Export

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Nikolov, Nikolay

NCT04469686 / 2019-003596-19: Phase 3 Study to Evaluate the Safety and Efficacy of Hydrocortisone Acetate Suppositories

Completed

200

Twice daily 90 mg hydrocortisone acetate suppository administered with Sephure applicator, Twice Daily - Active, Once daily 90 mg hydrocortisone acetate or placebo suppository administered with Sephure applicator, Once Daily - Active, Twice daily placebo suppository administered with Sephure applicator, Twice Daily - Placebo

Cristcot LLC, Cristcot HCA LLC

Ulcerative Proctitis

07/24

09/24

ELCIN, NCT05596409: ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study

Recruiting

Europe, US, RoW

Elacestrant

Stemline Therapeutics, Inc.

Metastatic Breast Cancer

01/26

07/27